• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重程度评分对社区获得性肺炎病死率预测价值的系统评价和荟萃分析。

Value of severity scales in predicting mortality from community-acquired pneumonia: systematic review and meta-analysis.

机构信息

School of Medicine, Health Policy and Practice, University of East Anglia, Norwich, Norfolk, UK.

出版信息

Thorax. 2010 Oct;65(10):884-90. doi: 10.1136/thx.2009.134072. Epub 2010 Aug 20.

DOI:10.1136/thx.2009.134072
PMID:20729235
Abstract

BACKGROUND

Several scoring systems have been used to predict mortality in patients with community-acquired pneumonia. The properties of commonly used risk stratification scales were systematically reviewed.

METHODS

MEDLINE and EMBASE (January 1999-October 2009) were searched for prospective studies that reported mortality at 4-8 weeks in patients with radiographically-confirmed community-acquired pneumonia. The search focused on the Pneumonia Severity Index (PSI) and the three main iterations of the CURB (confusion, urea nitrogen, respiratory rate, blood pressure) scale (CURB-65, CURB, CRB-65), and test performance was evaluated based on 'higher risk' categories as follows: PSI class IV/V, CURB-65 (score ≥ 3), CURB (score ≥ 2) and CRB-65 (score ≥ 2). Random effects meta-analysis was used to generate summary statistics of test performance and receiver operating characteristic curves were used for predicting mortality.

RESULTS

402 articles were screened and 23 studies involving 22,753 participants (average mortality 7.4%) were retrieved. The respective diagnostic odds ratios for mortality were 10.77 (PSI), 6.40 (CURB-65), 5.97 (CRB-65) and 5.75 (CURB). Overall, PSI had the highest sensitivity and lowest specificity for mortality, CRB-65 was the most specific (but least sensitive) test and CURB-65/CURB were between the two. Negative predictive values for mortality were similar among the tests, ranging from 0.94 (CRB-65) to 0.98 (PSI), whereas positive predictive values ranged from 0.14 (PSI) to 0.28 (CRB-65).

CONCLUSIONS

The current risk stratification scales (PSI, CURB-65, CRB-65 and CURB) have different strengths and weaknesses. All four scales had good negative predictive values for mortality in populations with a low prevalence of death but were less useful with regard to positive predictive values.

摘要

背景

有几种评分系统被用于预测社区获得性肺炎患者的死亡率。本研究系统地评价了常用风险分层量表的特征。

方法

检索 MEDLINE 和 EMBASE(1999 年 1 月至 2009 年 10 月)中前瞻性研究,报道经影像学证实的社区获得性肺炎患者 4-8 周死亡率。检索重点是肺炎严重指数(PSI)和 CURB(意识模糊、尿素氮、呼吸频率、血压)量表的三个主要迭代(CURB-65、CURB、CRB-65),并根据“高危”类别评价测试性能,如下:PSI 分级 IV/V、CURB-65(评分≥3)、CURB(评分≥2)和 CRB-65(评分≥2)。采用随机效应荟萃分析生成测试性能汇总统计量,采用受试者工作特征曲线预测死亡率。

结果

筛选出 402 篇文章,检索到 23 项研究共涉及 22753 例患者(平均死亡率 7.4%)。死亡率的诊断优势比分别为 10.77(PSI)、6.40(CURB-65)、5.97(CRB-65)和 5.75(CURB)。PSI 对死亡率的敏感性最高,特异性最低,CRB-65 是最特异(但最不敏感)的测试,而 CURB-65/CURB 则介于两者之间。死亡率的阴性预测值在各试验中相似,范围为 0.94(CRB-65)至 0.98(PSI),而阳性预测值范围为 0.14(PSI)至 0.28(CRB-65)。

结论

目前的风险分层量表(PSI、CURB-65、CRB-65 和 CURB)各有优缺点。所有四个量表在死亡率低的人群中对死亡率都有较好的阴性预测值,但阳性预测值都不高。

相似文献

1
Value of severity scales in predicting mortality from community-acquired pneumonia: systematic review and meta-analysis.严重程度评分对社区获得性肺炎病死率预测价值的系统评价和荟萃分析。
Thorax. 2010 Oct;65(10):884-90. doi: 10.1136/thx.2009.134072. Epub 2010 Aug 20.
2
Prediction of severe community-acquired pneumonia: a systematic review and meta-analysis.重症社区获得性肺炎的预测:一项系统评价和荟萃分析。
Crit Care. 2012 Jul 27;16(4):R141. doi: 10.1186/cc11447.
3
Severity assessment tools for predicting mortality in hospitalised patients with community-acquired pneumonia. Systematic review and meta-analysis.用于预测社区获得性肺炎住院患者死亡率的严重程度评估工具。系统评价和荟萃分析。
Thorax. 2010 Oct;65(10):878-83. doi: 10.1136/thx.2009.133280. Epub 2010 Aug 20.
4
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
6
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
7
Non-invasive diagnostic tests for Helicobacter pylori infection.幽门螺杆菌感染的非侵入性诊断测试。
Cochrane Database Syst Rev. 2018 Mar 15;3(3):CD012080. doi: 10.1002/14651858.CD012080.pub2.
8
CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).脑脊液tau蛋白及脑脊液tau蛋白与β淀粉样蛋白比值在轻度认知障碍(MCI)患者中用于诊断阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Mar 22;3(3):CD010803. doi: 10.1002/14651858.CD010803.pub2.
9
The Value of Soluble Urokinase Plasminogen Activator Receptor (suPAR) as Predictive Tool in Hospitalised Patients With Community-Acquired Pneumonia (CAP).可溶性尿激酶型纤溶酶原激活物受体(suPAR)作为社区获得性肺炎(CAP)住院患者预测工具的价值
Clin Respir J. 2025 Jun;19(6):e70089. doi: 10.1111/crj.70089.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.

引用本文的文献

1
Comparative Prognostic Accuracy of Clinical and Inflammation- or Nutrition-Based Scores in Older Adults with Community-Acquired Pneumonia.社区获得性肺炎老年患者中临床评分与基于炎症或营养的评分的比较预后准确性
Int J Gen Med. 2025 Aug 27;18:4811-4824. doi: 10.2147/IJGM.S540730. eCollection 2025.
2
Development and validation of mortality risk prediction model for sepsis secondary to pneumonia at intensive care unit admission: a retrospective case-cohort study.重症监护病房入院时肺炎继发脓毒症死亡风险预测模型的开发与验证:一项回顾性病例队列研究
Front Med (Lausanne). 2025 Aug 12;12:1592325. doi: 10.3389/fmed.2025.1592325. eCollection 2025.
3
Lactate to albumin ratio as a determinant of intensive care unit admission and mortality in hospitalized patients with community-acquired pneumonia.
乳酸与白蛋白比值作为社区获得性肺炎住院患者入住重症监护病房及死亡的决定因素
BMC Pulm Med. 2025 May 9;25(1):224. doi: 10.1186/s12890-025-03698-7.
4
Comparing large scale and selected feature learning for community acquired pneumonia prognosis prediction using clinical data: a stacked ensemble approach.使用临床数据比较大规模和选定特征学习在社区获得性肺炎预后预测中的应用:一种堆叠集成方法。
Sci Rep. 2025 Apr 10;15(1):12319. doi: 10.1038/s41598-025-95941-8.
5
Hyaluronic Acid is Associated with Severity and Prognosis in Patients with Community-Acquired Pneumonia.透明质酸与社区获得性肺炎患者的病情严重程度及预后相关。
J Inflamm Res. 2024 Dec 30;17:11829-11843. doi: 10.2147/JIR.S499326. eCollection 2024.
6
Effect of pre-hospital living setting on nutritional intake route upon discharge in older adults with aspiration pneumonia: a prospective cohort study.院前生活环境对老年吸入性肺炎患者出院时营养摄入途径的影响:一项前瞻性队列研究。
BMC Geriatr. 2025 Jan 4;25(1):10. doi: 10.1186/s12877-024-05659-x.
7
The management of community-acquired pneumonia in adults at a rural regional hospital in KwaZulu Natal.夸祖鲁-纳塔尔省农村地区医院成人社区获得性肺炎的管理
BMC Infect Dis. 2024 Sep 2;24(1):896. doi: 10.1186/s12879-024-09705-2.
8
Controversies in the management of community-acquired pneumonia in adults.成人社区获得性肺炎管理中的争议
Aust Prescr. 2024 Jun;47(3):80-84. doi: 10.18773/austprescr.2024.024.
9
Mortality in clostridioides difficile infection among patients hospitalized at the university clinical hospital in Wroclaw, Poland - a 3-year observational study.波兰弗罗茨瓦夫大学附属医院住院患者艰难梭菌感染死亡率:一项为期 3 年的观察性研究。
BMC Infect Dis. 2024 Jun 23;24(1):625. doi: 10.1186/s12879-024-09495-7.
10
Community-acquired pneumonia: use of clinical characteristics of acutely admitted patients for the development of a diagnostic model - a cross-sectional multicentre study.社区获得性肺炎:利用急性入院患者的临床特征建立诊断模型 - 一项横断面多中心研究。
BMJ Open. 2024 May 30;14(5):e079123. doi: 10.1136/bmjopen-2023-079123.